Transethosomes Novel Carrier: Promising Ultra deformable system for topical drug delivery

Abstract

Lipid nanoparticles have been the subject of much investigation as frontline nanocarriers for medication and vaccine formulations due to the growing demand for novel drug delivery strategies. With benefits over conventional formulations such as reduced plasma fluctuations, first-pass metabolism, organ toxicity, and low bioavailability, transethosomes have come to light as a potentially effective treatment. This thorough analysis looks at manufacturing methods and assessment attributes for effective drug delivery, as well as the effects of formulation elements on the characteristics and efficient targeting of transethosomes. In order to demonstrate the adaptability and possibility for controlled release of transethosomes, the review also looks at their numerous routes of administration, such as transdermal, transvaginal, pulmonary, and ocular delivery. The review also looks at how photodynamic treatment and functionalization could improve the effectiveness of medication delivery